Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2025 Filed Apr 23, 2025 21:28 UTC |
Yoshiyama AnnieSVP, Finance
|
SaleCommon Stock | 9,601 | $1.41 | $13,537.41 |
DisclosureSEC source: 0001835208-25-000007 · wk-form4_1745443726.xml · nonDerivative · entry 1 Yoshiyama Annie · CIK 0001835208 · SVP, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,663 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 2274 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 pursuant to an employee stock purchase program. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:28 UTC |
Beneski Benjamin MachinasSVP, Chief Technical Officer
|
SaleCommon Stock | 5,488 | $1.98 | $10,838.80 |
DisclosureSEC source: 0001737287-25-000040 · wk-form4_1742333277.xml · nonDerivative · entry 1 Beneski Benjamin Machinas · CIK 0002057918 · SVP, Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,507 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in one transaction at the single price point of $1.975. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at the price set forth above. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:30 UTC |
Chang David DDirector · President and CEO
|
SaleCommon Stock | 46,668 | $1.96 | $91,469.28 |
DisclosureSEC source: 0001737287-25-000042 · wk-form4_1742333443.xml · nonDerivative · entry 1 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,276,569 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in one transaction at a single price point of $1.96. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at the price set forth above. F3 · balance_after: Includes 6000 shares of the Issuer's common stock acquired by the reporting person on March 14, 2025 pursuant to an employee stock purchase program. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 21:11 UTC |
Beneski Benjamin MachinasSVP, Chief Technical Officer
|
GrantStock Option (Right to buy) · Derivative | 112,339 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001737287-25-000026 · wk-form4_1741209067.xml · derivative · entry 2 Beneski Benjamin Machinas · CIK 0002057918 · SVP, Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,339 Underlying: Common Stock · 112,339 shares Expires 2035-03-01 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 21:11 UTC |
Beneski Benjamin MachinasSVP, Chief Technical Officer
|
GrantCommon Stock | 31,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000026 · wk-form4_1741209067.xml · nonDerivative · entry 1 Beneski Benjamin Machinas · CIK 0002057918 · SVP, Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,995 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:15 UTC |
MESSEMER DEBORAH M.Director
|
SaleCommon Stock | 13,313 | $2.43 | $32,350.59 |
DisclosureSEC source: 0001737287-25-000022 · wk-form4_1740086122.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,316 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.42 to $2.44, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:12 UTC |
Roberts ZacharyEVP of R&D
|
SaleCommon Stock | 18,832 | $1.70 | $32,014.40 |
DisclosureSEC source: 0001737287-25-000016 · wk-form4_1738789969.xml · nonDerivative · entry 1 Roberts Zachary · CIK 0001851044 · EVP of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 643,135 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 16:14 UTC |
MOORE TIMOTHY L.Chief Technical Officer
|
SaleCommon Stock | 14,746 | $1.71 | $25,215.66 |
DisclosureSEC source: 0001737287-25-000018 · wk-form4_1738790068.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,713 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.715, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:15 UTC |
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 4,361 | $1.73 | $7,544.53 |
DisclosureSEC source: 0001737287-25-000019 · wk-form4_1738790139.xml · nonDerivative · entry 1 Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,301,540 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:16 UTC |
Douglas Earl MartinSVP, General Counsel
|
SaleCommon Stock | 6,404 | $1.71 | $10,950.84 |
DisclosureSEC source: 0001737287-25-000020 · wk-form4_1738790190.xml · nonDerivative · entry 1 Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587,848 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:13 UTC |
Chang David DDirector · President and CEO
|
SaleCommon Stock | 46,003 | $1.68 | $77,285.04 |
DisclosureSEC source: 0001737287-25-000017 · wk-form4_1738790016.xml · nonDerivative · entry 1 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,317,237 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.68 to $1.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:13 UTC |
Roberts ZacharyEVP of R&D
|
GrantStock Option (Right to buy) · Derivative | 614,844 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001737287-25-000006 · wk-form4_1738113175.xml · derivative · entry 2 Roberts Zachary · CIK 0001851044 · EVP of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614,844 Underlying: Common Stock · 614,844 shares Expires 2035-01-24 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:13 UTC |
Roberts ZacharyEVP of R&D
|
GrantCommon Stock | 173,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000006 · wk-form4_1738113175.xml · nonDerivative · entry 1 Roberts Zachary · CIK 0001851044 · EVP of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 661,967 Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:15 UTC |
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to buy) · Derivative | 614,844 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001737287-25-000008 · wk-form4_1738113304.xml · derivative · entry 2 Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614,844 Underlying: Common Stock · 614,844 shares Expires 2035-01-24 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:15 UTC |
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 173,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000008 · wk-form4_1738113304.xml · nonDerivative · entry 1 Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305,901 Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:11 UTC |
Belldegrun ArieDirector
|
GrantStock Option (Right to buy) · Derivative | 1,307,927 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001737287-25-000005 · wk-form4_1738113099.xml · derivative · entry 6 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,307,927 Underlying: Common Stock · 1,307,927 shares Expires 2035-01-24 F5 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:11 UTC |
Belldegrun ArieDirector
|
GrantCommon Stock | 369,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000005 · wk-form4_1738113099.xml · nonDerivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,236,816 Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:16 UTC |
Douglas Earl MartinSVP, General Counsel
|
GrantStock Option (Right to buy) · Derivative | 512,370 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001737287-25-000009 · wk-form4_1738113364.xml · derivative · entry 2 Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 512,370 Underlying: Common Stock · 512,370 shares Expires 2035-01-24 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:16 UTC |
Douglas Earl MartinSVP, General Counsel
|
GrantCommon Stock | 144,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000009 · wk-form4_1738113364.xml · nonDerivative · entry 1 Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 594,252 Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:10 UTC |
Chang David DDirector · President and CEO
|
GrantStock Option (Right to buy) · Derivative | 1,952,130 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001737287-25-000004 · wk-form4_1738113042.xml · derivative · entry 5 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,952,130 Underlying: Common Stock · 1,952,130 shares Expires 2035-01-24 F5 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:10 UTC |
Chang David DDirector · President and CEO
|
GrantCommon Stock | 552,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000004 · wk-form4_1738113042.xml · nonDerivative · entry 1 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,363,240 F1 · balance_after: Includes 960 shares of the Issuer's common stock acquired by the reporting person on September 15, 2024 pursuant to an employee stock purchase program. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:14 UTC |
Yoshiyama AnnieSVP, Finance
|
GrantStock Option (Right to buy) · Derivative | 128,093 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001737287-25-000007 · wk-form4_1738113240.xml · derivative · entry 2 Yoshiyama Annie · CIK 0001835208 · SVP, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,093 Underlying: Common Stock · 128,093 shares Expires 2035-01-24 F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter. Read SEC document |
| January 24, 2025 Filed Jan 29, 2025 01:14 UTC |
Yoshiyama AnnieSVP, Finance
|
GrantCommon Stock | 36,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001737287-25-000007 · wk-form4_1738113240.xml · nonDerivative · entry 1 Yoshiyama Annie · CIK 0001835208 · SVP, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,990 Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 21:30 UTC |
Roberts ZacharyEVP of R&D
|
SaleCommon Stock | 27,199 | $1.78 | $48,414.22 |
DisclosureSEC source: 0001737287-25-000003 · wk-form4_1737667821.xml · nonDerivative · entry 1 Roberts Zachary · CIK 0001851044 · EVP of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,054 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.805, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with in the rage set forth above. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:53 UTC |
MESSEMER DEBORAH M.Director
|
SaleCommon Stock | 9,136 | $2.18 | $19,916.48 |
DisclosureSEC source: 0001737287-24-000081 · wk-form4_1733867628.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,629 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.16 to $2.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 21:05 UTC |
Humer Franz BDirector
|
SaleCommon Stock | 9,221 | $2.16 | $19,917.36 |
DisclosureSEC source: 0001737287-24-000079 · wk-form4_1733778343.xml · nonDerivative · entry 1 Humer Franz B · CIK 0001548072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,507 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.145 to $2.185, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 21, 2024 Filed Oct 23, 2024 20:21 UTC |
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 36,404 | $2.84 | $103,387.36 |
DisclosureSEC source: 0001737287-24-000065 · wk-form4_1729714884.xml · nonDerivative · entry 1 Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,131,988 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.82 to $2.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 3,974 shares of the Issuer's common stock acquired by the reporting person on September 15, 2024 pursuant to an employee stock purchase program. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 20:15 UTC |
Douglas Earl MartinSVP, General Counsel
|
Tax withholdingCommon Stock | 28,310 | $2.79 | $78,843.35 |
DisclosureSEC source: 0001593968-24-001096 · primary_01.xml · nonDerivative · entry 1 Douglas Earl Martin · CIK 0001362155 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,324 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:31 UTC |
MESSEMER DEBORAH M.Director
|
SaleCommon Stock | 18,641 | $2.28 | $42,488.43 |
DisclosureSEC source: 0001593968-24-000878 · primary_01.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,765 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:28 UTC |
Kazam Joshua ADirector
|
GrantStock Option (Right to buy) · Derivative | 191,082 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001593968-24-000836 · primary_01.xml · derivative · entry 1 Kazam Joshua A · CIK 0001221355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,082 Underlying: Common Stock · 191,082 shares Expires 2034-06-05 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:33 UTC |
SATO VICKI LDirector
|
GrantStock Option (Right to buy) · Derivative | 95,541 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001593968-24-000839 · primary_01.xml · derivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,541 Underlying: Common Stock · 95,541 shares Expires 2034-06-05 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:33 UTC |
SATO VICKI LDirector
|
GrantCommon Stock | 61,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000839 · primary_01.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,575 Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:30 UTC |
Humer Franz BDirector
|
GrantStock Option (Right to buy) · Derivative | 95,541 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001593968-24-000838 · primary_01.xml · derivative · entry 2 Humer Franz B · CIK 0001548072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,541 Underlying: Common Stock · 95,541 shares Expires 2034-06-05 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:30 UTC |
Humer Franz BDirector
|
GrantCommon Stock | 61,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000838 · primary_01.xml · nonDerivative · entry 1 Humer Franz B · CIK 0001548072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,728 Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:29 UTC |
WITTE OWEN N.Director
|
GrantStock Option (Right to buy) · Derivative | 191,082 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001593968-24-000837 · primary_01.xml · derivative · entry 1 WITTE OWEN N. · CIK 0001700969 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,082 Underlying: Common Stock · 191,082 shares Expires 2034-06-05 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:35 UTC |
Mayo StephenDirector
|
GrantStock Option (Right to buy) · Derivative | 191,082 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001593968-24-000841 · primary_01.xml · derivative · entry 1 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,082 Underlying: Common Stock · 191,082 shares Expires 2034-06-05 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:34 UTC |
Barrett Elizabeth A.Director
|
GrantStock Option (Right to buy) · Derivative | 191,082 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001593968-24-000840 · primary_01.xml · derivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,082 Underlying: Common Stock · 191,082 shares Expires 2034-06-05 F1 · derivative.exercise_date: Vesting in 12 equal monthly installments Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:25 UTC |
MESSEMER DEBORAH M.Director
|
GrantCommon Stock | 122,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000835 · primary_01.xml · nonDerivative · entry 1 MESSEMER DEBORAH M. · CIK 0001754424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,406 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:09 UTC |
Humer Franz BDirector
|
SaleCommon Stock | 11,200 | $2.34 | $26,181.12 |
DisclosureSEC source: 0001593968-24-000783 · primary_01.xml · nonDerivative · entry 1 Humer Franz B · CIK 0001548072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,253 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.31 to $2.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 16, 2024 Filed May 20, 2024 22:02 UTC |
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 344,828 | $2.90 | $1,000,001.20 |
DisclosureSEC source: 0001593968-24-000715 · primary_01.xml · nonDerivative · entry 1 Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,164,418 F1 · shares: These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering. Read SEC document |
| May 16, 2024 Filed May 21, 2024 01:33 UTC |
Belldegrun ArieDirector
|
PurchaseCommon Stock | 1,724,137 | $2.90 | $4,999,997.30 |
DisclosureSEC source: 0001737287-24-000042 · primary_doc.xml · nonDerivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,724,137 F3 · shares: Consists of 1,720,172 shares of common stock acquired by Vida Ventures III, L.P. and 3,965 shares of common stock acquired by Vida Ventures III A, L.P. from Goldman Sachs (the Underwriter) in a registered direct offering. F4 · ownership.nature: The securities are held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. Vida Ventures GP III, LLC is the manager of Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person is a Senior Managing Director of Vida Ventures GP III, LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| May 16, 2024 Filed May 21, 2024 01:33 UTC |
Belldegrun ArieDirector
|
GrantCommon Stock | 344,828 | $2.90 | $1,000,001.20 |
DisclosureSEC source: 0001737287-24-000042 · primary_doc.xml · nonDerivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 539,867 F1 · shares: These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering. F2 · ownership.nature: The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun. Read SEC document |
| May 16, 2024 Filed May 20, 2024 22:01 UTC |
Chang David DDirector · President and CEO
|
GrantCommon Stock | 344,828 | $2.90 | $1,000,001.20 |
DisclosureSEC source: 0001593968-24-000714 · primary_01.xml · nonDerivative · entry 1 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,810,106 F1 · shares: These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 16:18 UTC |
MOORE TIMOTHY L.Chief Technical Officer
|
Tax withholdingCommon Stock | 17,360 | $3.47 | $60,188.86 |
DisclosureSEC source: 0001593968-24-000614 · primary_01.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,459 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.44 to $3.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| March 14, 2024 Filed Mar 19, 2024 00:10 UTC |
Chang David DDirector · President and CEO
|
Tax withholdingCommon Stock | 53,393 | $4.33 | $231,191.69 |
DisclosureSEC source: 0001593968-24-000477 · primary_01.xml · nonDerivative · entry 1 Chang David D · CIK 0001611024 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,465,278 F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes 5,468 shares of the Issuer's common stock acquired by the reporting person on March 15, 2024 pursuant to an employee stock purchase program. Read SEC document |
| January 30, 2024 Filed Mar 7, 2024 02:52 UTC |
Parker Geoffrey M.CHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 190 | $3.60 | $683.05 |
DisclosureSEC source: 0001593968-24-000449 · primary_01.xml · nonDerivative · entry 1 Parker Geoffrey M. · CIK 0001491874 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 819,590 F1 · shares: Mr. Parker was notified by his broker on March 4, 2024 that these shares were purchased in an account held by the Geoffrey M. Parker and Jill G. Parker Rev. Trust dated January 27, 2000 for which Mr. Parker does not have discretion. This account is intended to closely track the performance of the Russell 2000 and is frequently rebalanced by an algorithm designed by the broker which led to the purchase of these shares. Restrictions have been now placed on all such accounts held by the Trust to avoid such purchases of the Issuer stock in the future. Read SEC document |
| January 25, 2024 Filed Jan 31, 2024 22:45 UTC |
Roberts ZacharyEVP of R&D
|
GrantStock Option (Right to buy) · Derivative | 494,949 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001593968-24-000193 · primary_01.xml · derivative · entry 2 Roberts Zachary · CIK 0001851044 · EVP of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,949 Underlying: Common Stock · 494,949 shares Expires 2034-01-25 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter. Read SEC document |
| January 25, 2024 Filed Jan 31, 2024 22:45 UTC |
Roberts ZacharyEVP of R&D
|
GrantCommon Stock | 140,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000193 · primary_01.xml · nonDerivative · entry 1 Roberts Zachary · CIK 0001851044 · EVP of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 515,253 Read SEC document |
| January 25, 2024 Filed Jan 31, 2024 17:51 UTC |
MOORE TIMOTHY L.Chief Technical Officer
|
GrantStock Option (Right to buy) · Derivative | 341,515 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001593968-24-000197 · primary_01.xml · derivative · entry 2 MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,515 Underlying: Common Stock · 341,515 shares Expires 2034-01-25 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter. Read SEC document |
| January 25, 2024 Filed Jan 31, 2024 17:51 UTC |
MOORE TIMOTHY L.Chief Technical Officer
|
GrantCommon Stock | 96,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000197 · primary_01.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,819 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.